19 July 2018Americas

Cantor Colburn adds new chair to life sciences group

US-based law firm Cantor Colburn has hired Bryan Zerhusen as a partner and chair of the firm’s life sciences practice group.

He joins from Locke Lord, where he was co-chair of the life sciences practice group.

Zerhusen is experienced in helping clients with licensing, patent portfolio management and development, and global patent strategy in the areas of biotechnology, pharmaceuticals and chemical matters.

He has worked with a range of clients including individual inventors, private colleges and universities, and pharmaceutical and biotechnology start-up companies.

Michael Cantor, co-managing partner of Cantor Colburn, said Zerhusen is a “great addition” to the firm’s life sciences practice.

“Bryan is well-known for being a leader with a steady grasp of complex technologies and for having a track-record of outstanding client service,” said Cantor. “His addition is terrific news for our life sciences clients.”

Zerhusen added that Cantor Colburn is a “natural fit” for him and his clients.

He said: “Cantor Colburn is an IP powerhouse with a robust team of patent practitioners in both the chemical and life sciences areas to support and complement my practice.”

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.


More on this story

Americas
25 August 2017   Law firm Cantor Colburn has achieved the highest rate of successful allowances for patent applications following section 101 rejections citing the Mayo and Myriad precedents, according to data compiled by research firm Juristat.

More on this story

Americas
25 August 2017   Law firm Cantor Colburn has achieved the highest rate of successful allowances for patent applications following section 101 rejections citing the Mayo and Myriad precedents, according to data compiled by research firm Juristat.